Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 03 04:00PM ET
1.96
Dollar change
-0.06
Percentage change
-2.97
%
Index- P/E- EPS (ttm)-1.05 Insider Own3.93% Shs Outstand100.09M Perf Week0.00%
Market Cap141.30M Forward P/E- EPS next Y-0.76 Insider Trans0.00% Shs Float69.26M Perf Month8.89%
Income-85.55M PEG- EPS next Q-0.18 Inst Own13.62% Short Float0.20% Perf Quarter-14.78%
Sales29.07M P/S4.86 EPS this Y64.22% Inst Trans-0.81% Short Ratio2.63 Perf Half Y-23.74%
Book/sh1.29 P/B1.52 EPS next Y-19.47% ROA-34.45% Short Interest0.14M Perf Year-35.53%
Cash/sh3.62 P/C0.54 EPS next 5Y- ROE-101.50% 52W Range1.70 - 3.77 Perf YTD-36.36%
Dividend Est.- P/FCF2.37 EPS past 5Y1.69% ROI-37.57% 52W High-48.06% Beta3.07
Dividend TTM- Quick Ratio1.78 Sales past 5Y42.86% Gross Margin33.41% 52W Low15.29% ATR (14)0.11
Dividend Ex-Date- Current Ratio1.78 EPS Y/Y TTM38.67% Oper. Margin-311.06% RSI (14)50.42 Volatility4.65% 5.46%
Employees221 Debt/Eq0.87 Sales Y/Y TTM76.24% Profit Margin-294.25% Recom1.67 Target Price5.67
Option/ShortYes / Yes LT Debt/Eq0.76 EPS Q/Q26.77% Payout- Rel Volume0.56 Prev Close2.02
Sales Surprise84.74% EPS Surprise-13.24% Sales Q/Q10351.61% EarningsNov 04 AMC Avg Volume53.46K Price1.96
SMA201.65% SMA501.02% SMA200-15.37% Trades Volume29,908 Change-2.97%
Date Action Analyst Rating Change Price Target Change
Mar-17-23Initiated Bryan Garnier Buy $6
May-18-22Upgrade Robert W. Baird Neutral → Outperform $10
Jan-06-22Downgrade Wells Fargo Overweight → Equal Weight $39 → $16
Nov-30-21Initiated JMP Securities Mkt Outperform $20
Nov-08-21Downgrade William Blair Outperform → Mkt Perform
Oct-08-21Downgrade Robert W. Baird Outperform → Neutral $39 → $10
Apr-28-21Downgrade Guggenheim Buy → Neutral
Mar-16-21Upgrade Robert W. Baird Neutral → Outperform $23 → $39
Aug-19-20Upgrade Citigroup Neutral → Buy $15 → $32
May-12-20Initiated Robert W. Baird Outperform $20
Nov-06-24 04:38PM
Nov-05-24 04:30PM
Nov-04-24 04:30PM
07:14AM
Oct-30-24 04:30PM
06:29AM Loading…
Oct-23-24 06:29AM
Oct-22-24 02:00AM
Oct-02-24 04:30PM
Sep-04-24 04:30PM
Sep-03-24 04:30PM
Aug-26-24 04:30PM
Aug-07-24 02:00AM
Aug-06-24 04:30PM
Aug-05-24 04:30PM
Aug-02-24 09:53AM
04:30PM Loading…
Aug-01-24 04:30PM
Jul-25-24 04:30PM
Jul-10-24 09:35AM
Jul-05-24 04:30PM
Jun-28-24 04:30PM
Jun-20-24 04:30PM
Jun-18-24 12:00PM
09:35AM
Jun-12-24 04:30PM
Jun-05-24 04:30PM
Jun-04-24 04:30PM
May-29-24 04:30PM
May-28-24 08:52PM
04:30PM
May-27-24 04:30PM
04:30PM Loading…
May-16-24 04:30PM
May-06-24 04:30PM
04:22AM
02:00AM
May-03-24 06:10AM
May-02-24 04:30PM
Apr-29-24 10:53PM
04:46PM
Apr-22-24 04:30PM
Apr-10-24 04:30PM
Apr-08-24 04:30PM
Apr-04-24 04:30PM
Mar-04-24 04:30PM
Feb-02-24 04:30PM
Jan-16-24 04:30PM
Jan-08-24 04:30PM
Dec-22-23 04:30PM
Dec-01-23 04:30PM
Nov-17-23 04:30PM
Nov-15-23 02:30AM
Nov-06-23 04:30PM
Nov-03-23 04:30PM
Nov-02-23 04:30PM
Nov-01-23 04:30PM
08:13AM
08:02AM
03:00AM
Oct-31-23 04:30PM
Oct-24-23 04:30PM
Oct-12-23 04:30PM
Oct-03-23 04:30PM
09:55AM
Sep-27-23 04:30PM
Sep-05-23 04:30PM
Aug-07-23 04:30PM
Aug-03-23 04:30PM
Aug-01-23 04:30PM
Jul-27-23 04:30PM
Jul-12-23 04:30PM
Jun-28-23 04:30PM
Jun-13-23 04:30PM
Jun-09-23 04:30PM
Jun-05-23 04:30PM
May-31-23 04:50PM
May-17-23 04:30PM
May-12-23 01:30AM
May-11-23 10:20AM
May-10-23 04:30PM
May-04-23 04:30PM
May-02-23 04:35PM
Apr-27-23 04:30PM
Apr-24-23 04:30PM
Apr-17-23 02:00AM
Apr-12-23 04:30PM
Apr-11-23 04:30PM
Apr-04-23 04:30PM
Mar-15-23 05:02PM
Mar-14-23 05:00PM
Mar-08-23 04:45PM
Mar-06-23 04:30PM
Mar-01-23 04:30PM
Feb-09-23 04:30PM
Feb-07-23 07:01PM
Feb-03-23 09:33AM
12:48AM
Feb-02-23 04:01PM
Jan-30-23 07:10PM
Jan-20-23 04:30PM
Jan-17-23 07:10AM
Jan-09-23 04:30PM
Cellectis SA operates as a clinical stage biotechnological company, which engages in gene-editing platform to develop cell and gene therapies. The company was founded by David J. Sourdive and Andre Choulika on February 20, 1999 and is headquartered in Paris, France.